CT screening for lung cancer: Are we ready to implement in Europe?
Early detection
Low-dose CT (LDCT)
Lung cancer
Lung cancer screening
Journal
Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
04
03
2019
revised:
12
05
2019
accepted:
26
05
2019
entrez:
20
7
2019
pubmed:
20
7
2019
medline:
23
6
2020
Statut:
ppublish
Résumé
Lung cancer screening with low-dose CT (LDCT) is already available in certain parts of the world, such as the United States, but not yet in Europe. The recently published European position statement on lung cancer screening has recommended planning for implementation of screening to start within 18-months [1]. Pilot European programmes are already underway, primarily in the United Kingdom (UK), delivering lung cancer screening to their local populations. This review article acknowledges the evidence base for LDCT screening and will discuss the challenges that still need to be overcome in an attempt to answer the question: are we ready to implement in Europe?
Identifiants
pubmed: 31319989
pii: S0169-5002(19)30472-6
doi: 10.1016/j.lungcan.2019.05.028
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
25-33Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.